Biotech Values

[Double_Bagel]

Doesn't this mean some good news for MNTA? All the more reason for Amphastar not to launch as they are a tiny company and will risk bankruptcy if they lose and have to pay damages.

What do you make of the statement by Watson (see MNta board) that boasts that they are fully indemnified by Amphastar? I suppose as a public company they are required to inform on this point. However isn't that a sign that Watson has incentives to launch at risk and stick Amphastart with the risk? Thus a reason making settlement less likely.